Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Boston
Biotech
Mass. biotechs bring in VC dollars but see workforce shrink
A new report on the health of the Massachusetts biotech scene has painted a mixed picture of how drug developers are faring in the Bay State.
Will Maddox
Aug 25, 2026 5:00am
Boston, China and the future of biotech
May 29, 2026 9:09am
Spain's Boston biotech initiative aims to raise $200M VC fund
Apr 15, 2026 10:20am
Takeda consolidates Boston footprint
Feb 11, 2026 3:51pm
Chinese CRO ChemPartner gets ready to debut US research facility
Aug 26, 2025 2:57pm
Roche's $50B US investment to include upcoming Boston CVRM site
Apr 22, 2025 5:10am
